(Q54500899)
Statements
Randomized phase III trial of temsirolimus and bevacizumab versus interferon alfa and bevacizumab in metastatic renal cell carcinoma: INTORACT trial. (English)
Bernard Escudier
1 reference
Brian I Rini
Joaquim Bellmunt
Jill Clancy
Kongming Wang
Andreas G Niethammer
Subramanian Hariharan
2 December 2013
32
8
752-759